NASDAQ:PRXL - PAREXEL International Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$88.08
+0.30 (1.20%)
Get New PAREXEL International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PRXL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PRXL

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for PAREXEL International in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $88.08.

This chart shows the closing price for PRXL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in PAREXEL International. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/5/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/4/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/4/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/21/2017Jefferies Financial GroupReiterated RatingHold$88.10Low
6/20/2017BarclaysDowngradeOverweighr ➝ Equal Weight$87.00High
6/20/2017Raymond JamesUpgradeUnderperform ➝ Mkt PerformHigh
6/6/2017Credit Suisse GroupReiterated RatingNeutral$65.00 ➝ $83.00Low
5/30/2017MizuhoBoost Price TargetBuy ➝ Buy$66.00 ➝ $75.00Low
5/23/2017The Goldman Sachs GroupUpgradeSell ➝ Neutral$63.00 ➝ $77.00Low
5/17/2017BarclaysReiterated RatingOverweight$87.00Low
5/15/2017Evercore ISIUpgradeIn-Line ➝ Outperform$85.00Low
3/23/2017MizuhoInitiated CoverageNeutral$86.00Low
2/6/2017Credit Suisse GroupDowngradeOutperform ➝ NeutralN/A
2/5/2017Credit Suisse GroupReiterated RatingOutperform ➝ Neutral$68.00 ➝ $65.00N/A
2/3/2017Deutsche Bank AktiengesellschaftDowngradeHold ➝ Sell$66.00 ➝ $53.00N/A
2/3/2017CitigroupDowngradeBuy ➝ NeutralN/A
2/2/2017UBS GroupDowngradeMarket Perform ➝ UnderperformN/A
2/2/2017Raymond JamesDowngradeMarket Perform ➝ UnderperformN/A
1/24/2017Jefferies Financial GroupBoost Price TargetHold$64.00 ➝ $67.00N/A
1/4/2017Evercore ISIDowngradeBuy ➝ Hold$71.50N/A
12/23/2016Deutsche Bank AktiengesellschaftReiterated RatingHold$66.00N/A
12/16/2016The Goldman Sachs GroupDowngradeNeutral ➝ SellN/A
(Data available from 12/4/2016 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/8/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/7/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/7/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/6/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/5/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/5/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/4/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/4/2021

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
PAREXEL International logo
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions.
Read More

Today's Range

Now: $88.08
Low: $88.08
High: $88.08

50 Day Range

MA: $88.08
Low: $88.08
High: $88.08

52 Week Range

Now: $88.08
Low: $51.16
High: $88.10

Volume

N/A

Average Volume

1,041,144 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of PAREXEL International?

The following equities research analysts have issued reports on PAREXEL International in the last twelve months:
View the latest analyst ratings for PRXL.

What is the current price target for PAREXEL International?

0 Wall Street analysts have set twelve-month price targets for PAREXEL International in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for PAREXEL International in the next year.
View the latest price targets for PRXL.

What is the current consensus analyst rating for PAREXEL International?

PAREXEL International currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for PRXL.

How do I contact PAREXEL International's investor relations team?

PAREXEL International's physical mailing address is 195 West St, WALTHAM, MA 02451-1111, United States. The medical research company's listed phone number is +1-781-4879900. The official website for PAREXEL International is www.parexel.com.